ATE286073T1 - Antikörper gegen spaltprodukte von vimentin - Google Patents

Antikörper gegen spaltprodukte von vimentin

Info

Publication number
ATE286073T1
ATE286073T1 AT00305736T AT00305736T ATE286073T1 AT E286073 T1 ATE286073 T1 AT E286073T1 AT 00305736 T AT00305736 T AT 00305736T AT 00305736 T AT00305736 T AT 00305736T AT E286073 T1 ATE286073 T1 AT E286073T1
Authority
AT
Austria
Prior art keywords
vimentin
antibodies against
against clip
products
clip products
Prior art date
Application number
AT00305736T
Other languages
English (en)
Inventor
Nobuhiro Morishima
Keiko Nakanishi
Takehiko Shibata
Original Assignee
Riken
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Riken filed Critical Riken
Application granted granted Critical
Publication of ATE286073T1 publication Critical patent/ATE286073T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT00305736T 1999-07-07 2000-07-07 Antikörper gegen spaltprodukte von vimentin ATE286073T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP19323599A JP3829226B2 (ja) 1999-07-07 1999-07-07 ビメンチンの切断産物に対する抗体

Publications (1)

Publication Number Publication Date
ATE286073T1 true ATE286073T1 (de) 2005-01-15

Family

ID=16304586

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00305736T ATE286073T1 (de) 1999-07-07 2000-07-07 Antikörper gegen spaltprodukte von vimentin

Country Status (6)

Country Link
US (2) US6417336B1 (de)
EP (1) EP1067142B1 (de)
JP (1) JP3829226B2 (de)
AT (1) ATE286073T1 (de)
DE (1) DE60017019T2 (de)
ES (1) ES2233291T3 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3829226B2 (ja) * 1999-07-07 2006-10-04 独立行政法人理化学研究所 ビメンチンの切断産物に対する抗体
US7691582B2 (en) * 2002-09-27 2010-04-06 The Regents Of The University Of Michigan Methods of secretory vimentin detection and modulation
WO2005062058A1 (en) * 2002-12-13 2005-07-07 Aurelium Biopharma Inc. Vimentin directed diagnostics and therapeutics for multidrug resistant neoplastic disease
US7670604B2 (en) 2002-12-13 2010-03-02 Aurelium Biopharma, Inc. Vimentin directed diagnostics and therapeutics for multidrug resistant neoplastic disease
WO2004055517A2 (en) * 2002-12-13 2004-07-01 Aurelium Biopharma Inc. Nucleophosmin directed diagnostics and therapeutics for multidrug resistant neoplastic disease
US7226748B2 (en) * 2003-01-03 2007-06-05 Aurelium Biopharma, Inc. HSC70 directed diagnostics and therapeutics for multidrug resistant neoplastic disease
WO2004080819A2 (en) * 2003-03-14 2004-09-23 Aurelium Biopharma Inc. Triosephosphate isomerase directed diagnostics and therapeutics for multidrug resistant neoplastic disease
JPWO2005105144A1 (ja) * 2004-04-30 2007-09-13 協和醗酵工業株式会社 潜在型TGF−βの活性化抑制剤
FR2875601B1 (fr) * 2004-09-17 2007-04-13 Genome Express S A Sa Vimentine phosphorylee comme marqueur de l'agressivite et/ou l'invasivite des tumeurs
WO2007052398A1 (ja) * 2005-11-01 2007-05-10 Reverse Proteomics Research Institute Co., Ltd. アレルギー疾患の治療に有用な化合物をスクリーニングする方法
US20070243561A1 (en) * 2006-02-16 2007-10-18 Ben Geeraerts Prognostic markers in chronic lymphocytic leukemia
BRPI0710884A2 (pt) * 2006-04-24 2011-08-16 Shantha West, Inc. polipeptìdeo isolado, ácido nucléico, célula transformada, vetor, composição farmacêutica, kit, e, métodos para identificar uma célula que expressa um polipeptìdeo, de triagem para um distúrbio proliferativo da célula, para induzir ou aumentar uma resposta imune a um polipeptìdeo, para tratar um indivìduo tendo, ou em risco de ter, um tumor, para identificar um inibidor ou estimulador da expressão de um polipeptìdeo, e para triar um indivìduo tendo, ou em risco de ter, um distúrbio proliferativo da célula
WO2016199964A1 (ko) * 2015-06-10 2016-12-15 주식회사 이뮨메드 분리된 비멘틴 유래 펩타이드에 특이적으로 결합하는 항체 또는 상기 펩타이드의 결합 단편
WO2019045182A1 (ko) 2017-08-31 2019-03-07 주식회사 이뮨메드 비멘틴 유래 펩타이드에 특이적으로 결합하는 물질을 포함하는 피부질환 예방 및 치료용 조성물
CN112618712A (zh) * 2021-01-21 2021-04-09 武汉轻工大学 一种含波形蛋白的佐剂及应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07258296A (ja) * 1994-03-28 1995-10-09 Science & Tech Agency 抗cdc2キナーゼリン酸化ビメンチンモノクローナル抗体
JP3829226B2 (ja) * 1999-07-07 2006-10-04 独立行政法人理化学研究所 ビメンチンの切断産物に対する抗体

Also Published As

Publication number Publication date
JP3829226B2 (ja) 2006-10-04
EP1067142A1 (de) 2001-01-10
EP1067142B1 (de) 2004-12-29
US7029864B2 (en) 2006-04-18
DE60017019T2 (de) 2005-12-22
JP2001017167A (ja) 2001-01-23
US20020137110A1 (en) 2002-09-26
US6417336B1 (en) 2002-07-09
DE60017019D1 (de) 2005-02-03
ES2233291T3 (es) 2005-06-16

Similar Documents

Publication Publication Date Title
ATE286073T1 (de) Antikörper gegen spaltprodukte von vimentin
CY2007012I1 (el) Αντισωματα anti-vegf
DK1489082T3 (da) Mellemprodukter
BR9808945B1 (pt) processamento de hidrocarbonetos gasosos.
CY1119291T1 (el) Πολυσθενη αντισωματα και χρησεις για αυτα
DE69737683D1 (de) Antikörper gegen die ed-b domäne von fibronektin, ihre herstellung und verwendungen
FR2703239B1 (fr) Agrafe pour prothèse inter-épineuse.
DE69527924D1 (de) Hitzebeständige xylanasen
ES2195970T3 (es) L-ribavirina y usos de la misma.
TR199902516T2 (xx) Kalsilitik bile�imleri.
DE69709561D1 (de) Östrogen-Rezeptor
BR9805028A (pt) Embreagem
NL1009154C2 (nl) Nieuwe verbindingen op basis van polyalkyl-1-oxa- diazaspirodecaanverbindingen.
ATE238451T1 (de) Leimungsemulsion
DE69634077D1 (de) Haemophilus adhäsionsproteinen
TR199800604A3 (tr) Anti-fas antikorlari.
PT929299E (pt) 1,2,3,4-tetra-hidro-2-dibenzofuranaminas e 2-aminociclo-hepta ¬b| benzofuranos substituidos
DE59608073D1 (de) Antikörper gegen ein, einen histidin-anteil aufweisendes fusionspolypeptid
ATE402959T1 (de) Antifucoidan antikörper
WO2000073345A3 (en) Antibodies specific for mycobacterial polypeptides and uses thereof
FR2776809B1 (fr) Support de presentation pour documents, affiches ou similaires
BR1100504A (pt) anticorpos anti-ige.
ATA82394A (de) Heizeinrichtung zur temperierung von kirchenräumen, insbesondere kleinkirchen od.dgl.
ES1025927Y (es) Pinza para la ropa.
ES1036972Y (es) Cartela para produccion de documentos.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties